Related references
Note: Only part of the references are listed.Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer
Satoshi Inoue et al.
ONCOLOGY LETTERS (2020)
Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma
Soichiro Kakimoto et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Favorable therapeutic response after anti-Mesothelin antibody-drug conjugate treatment requires high expression of Mesothelin in tumor cells
Lea Lazzerini et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
Current recommendations and recent progress in endometrial cancer
Rebecca A. Brooks et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The Prognosis of Stage IA Mixed Endometrial Carcinoma A Retrospective Cohort Study
Wenhui Li et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study
Christopher B. Nahm et al.
EJSO (2019)
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)
Naveena Singh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Mesothelin expression has prognostic value in stage / colorectal cancer
Takehiro Shiraishi et al.
VIRCHOWS ARCHIV (2019)
Mesothelin as a biomarker for targeted therapy
Jiang Lv et al.
BIOMARKER RESEARCH (2019)
Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study
Gitte Ortoft et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Immunohistochemical Profiling of Endometrial Serous Carcinoma
Wenqian Chen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2017)
Reproducibility of measurement of myometrial invasion in endometrial carcinoma
Louis J. M. van der Putten et al.
VIRCHOWS ARCHIV (2017)
The genetic landscape of endometrial clear cell carcinomas
Deborah F. DeLair et al.
JOURNAL OF PATHOLOGY (2017)
Mesothelin promotes epithelial-tomesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells
Xiaoqing He et al.
MOLECULAR CANCER (2017)
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
Raffit Hassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Colin D. Weekes et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Uterine carcinosarcoma: A review of the literature
Leigh A. Cantrell et al.
GYNECOLOGIC ONCOLOGY (2015)
Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms
Takahiro Einama et al.
ONCOLOGY LETTERS (2015)
Mesothelin expression is associated with poor outcomes in breast cancer
Yun R. Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Mildred Felder et al.
MOLECULAR CANCER (2014)
Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer
T. Einama et al.
BRITISH JOURNAL OF CANCER (2012)
Mesothelin expression correlates with prolonged patient survival in gastric cancer
Kenji Baba et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression
Uddalak Bharadwaj et al.
MOLECULAR CANCER (2011)
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma
Takahiro Einama et al.
PANCREAS (2011)
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma
Louis A. Dainty et al.
GYNECOLOGIC ONCOLOGY (2007)
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
Jennifer A. A. Gubbels et al.
MOLECULAR CANCER (2006)
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma
MJ Yen et al.
CLINICAL CANCER RESEARCH (2006)
Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion
A Rump et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tissue and serum CA125 expression in endometrial cancer
S Ginath et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
Share Paper
